Jagsonpal Pharmaceuticals Limited Net Asset Quality Index
Jagsonpal Pharmaceuticals Limited net asset quality index. Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) has a Net Asset Quality Index of 87.2% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Rs3.17 Billion minus total liabilities of Rs405.05 Million yields net assets of Rs2.76 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See net assets of Jagsonpal Pharmaceuticals Limited for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Jagsonpal Pharmaceuticals Limited (2006–2026)
Net asset quality index of Jagsonpal Pharmaceuticals Limited from 2006 to 2026. This chart shows how Jagsonpal Pharmaceuticals Limited's Net Asset Quality Index has evolved across 21 annual periods from 2006 to 2026. As of March 2026, the index stands at 87.2%, representing net assets of Rs2.76 Billion against total assets of Rs3.17 Billion INR. Check strategic asset allocation of Jagsonpal Pharmaceuticals Limited to assess the company's strategic physical and investment asset allocation.
Jagsonpal Pharmaceuticals Limited Net Asset Quality Index by Year (2006–2026)
Jagsonpal Pharmaceuticals Limited net asset quality index by year from 2006 to 2026. The table below presents the year-by-year Net Asset Quality Index for Jagsonpal Pharmaceuticals Limited from 2006 to 2026, covering 21 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see JAGSNPHARM market cap overview.
| Year | Quality Index | Net Assets (INR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2026 | 87.2% | Rs2.76 Billion | Rs3.17 Billion | Rs405.05 Million | ▲ +1.0 pp |
| 2025 | 86.2% | Rs2.40 Billion | Rs2.78 Billion | Rs383.10 Million | ▼ -0.1 pp |
| 2024 | 86.3% | Rs1.87 Billion | Rs2.17 Billion | Rs296.76 Million | ▲ +4.8 pp |
| 2023 | 81.5% | Rs1.59 Billion | Rs1.95 Billion | Rs360.56 Million | ▲ +3.8 pp |
| 2022 | 77.7% | Rs1.31 Billion | Rs1.68 Billion | Rs375.99 Million | ▲ +3.4 pp |
| 2021 | 74.3% | Rs1.22 Billion | Rs1.64 Billion | Rs422.73 Million | ▼ -1.3 pp |
| 2020 | 75.6% | Rs1.11 Billion | Rs1.47 Billion | Rs359.21 Million | ▼ -1.4 pp |
| 2019 | 76.9% | Rs1.04 Billion | Rs1.36 Billion | Rs313.11 Million | ▲ +1.4 pp |
| 2018 | 75.5% | Rs980.47 Million | Rs1.30 Billion | Rs317.68 Million | ▼ -1.5 pp |
| 2017 | 77.1% | Rs1.10 Billion | Rs1.43 Billion | Rs326.97 Million | ▲ +15.3 pp |
| 2016 | 61.8% | Rs983.64 Million | Rs1.59 Billion | Rs609.17 Million | ▼ -0.1 pp |
| 2015 | 61.9% | Rs954.26 Million | Rs1.54 Billion | Rs587.94 Million | ▼ -1.2 pp |
| 2014 | 63.1% | Rs985.89 Million | Rs1.56 Billion | Rs576.68 Million | ▼ -1.2 pp |
| 2013 | 64.3% | Rs983.71 Million | Rs1.53 Billion | Rs546.30 Million | ▲ +1.2 pp |
| 2012 | 63.1% | Rs984.69 Million | Rs1.56 Billion | Rs576.30 Million | ▼ -4.9 pp |
| 2011 | 68.0% | Rs929.14 Million | Rs1.37 Billion | Rs438.04 Million | ▼ -3.1 pp |
| 2010 | 71.1% | Rs875.70 Million | Rs1.23 Billion | Rs356.69 Million | ▲ +5.8 pp |
| 2009 | 65.3% | Rs801.68 Million | Rs1.23 Billion | Rs426.09 Million | ▲ +7.7 pp |
| 2008 | 57.6% | Rs750.34 Million | Rs1.30 Billion | Rs552.21 Million | ▲ +8.4 pp |
| 2007 | 49.2% | Rs724.98 Million | Rs1.47 Billion | Rs749.83 Million | ▼ -0.5 pp |
| 2006 | 49.6% | Rs702.35 Million | Rs1.42 Billion | Rs713.18 Million | — |